HN-0037

N/A

Report date: 2025/07/23 20:00:47
NME

Base Information

Drug NameHN-0037
Drug Alias NameHN-0037
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA helicase/primase complex inhibitors
TargetsDNA helicase/primase complex
Therapy Area/IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 InfectionsHerpes Labialis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHuinuo Biomedical Technology (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHuinuo Biomedical Technology (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 InfectionsHerpes Labialis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A